Study to Evaluate the PK of Single and Optional Multiple Dosing Regimens of MR Formulations of PCS499 Compared to Trental® Administered to Healthy Subjects
Clinical trial NCT03836222 · COMPLETED
Trial details
- NCT number
- NCT03836222
- Sponsor
- Processa Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-26
- Primary completion
- 2018-06-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.